Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 18, Number 8—August 2012
Dispatch

Escherichia coli O104 Associated with Human Diarrhea, South Africa, 2004–2011

Nomsa P. TauComments to Author , Parastu Meidany, Anthony M. Smith, Arvinda Sooka, Karen H. Keddy, and for the Group for Enteric, Respiratory, and Meningeal Disease Surveillance in South Africa
Author affiliations: National Health Laboratory Services, Johannesburg, South Africa (N.P. Tau, A.M. Smith, A. Sooka, K.H. Keddy); University of the Witwatersrand, Johannesburg (P. Meidany, A.M. Smith, K.H. Keddy)

Main Article

Table 2

Escherichia coli O104 strains associated with human diarrhea, South Africa, 2004–2011*

Strain no. Collection date Province Patient age/sex E. coli pathotype H antigen Antimicrobial drug susceptibility†
1 2007 Feb 23 Eastern Cape 4 mo/F EAggEC H4 RAmp SAmc RSxt SChl SNal SCip RTet SKan SStr SImi SCro SCaz
2 2007 Nov 16 Mpumalanga 43 y/M EAggEC H4 RAmp SAmc RSxt SChl SNal SCip RTet SKan RStr SImi SCro SCaz
3 2009 Apr 12 Gauteng 10 mo/F EPEC Non-H4 SAmp SAmc SSxt SChl SNal SCip STet SKan SStr SImi SCro SCaz
4 2010 Feb 24 Mpumalanga 7 mo/M EAggEC H4 RAmp SAmc RSxt SChl SNal SCip STet SKan SStr SImi SCro SCaz
5 2010 Mar 3 North West 7 mo/F EAggEC H4 RAmp SAmc RSxt SChl SNal SCip RTet SKan SStr SImi SCro SCaz
6 2010 Jun 16 Gauteng 12 mo/M EAggEC H4 RAmp SAmc RSxt SChl SNal SCip STet SKan RStr SImi SCro SCaz
7 2010 Jul 17 Gauteng 15 mo/F EPEC Non-H4 SAmp SAmc SSxt SChl SNal SCip STet SKan SStr SImi SCro SCaz

*EaggEC, enteroaggregative E. coli; EPEC, enteropathogenic E. coli.
†R, resistant; S, susceptible. Isolates were classified as antimicrobial drug resistant at the following MIC breakpoint concentrations: ampicillin (Amp), MIC >16 μg/mL; amoxicillin/clavulanic acid (Amc), MIC >16 μg/mL; sulfamethoxazole/trimethoprim (Sxt), MIC >4 μg/mL; chloramphenicol (Chl), MIC >16 μg/mL; nalidixic acid (Nal), MIC >32 μg/mL; ciprofloxacin (Cip), MIC >2 μg/mL; tetracycline (Tet), MIC >8 μg/mL; kanamycin (Kan), MIC >32 μg/mL; streptomycin (Str), MIC >64 μg/mL; imipenem (Imi), MIC >8 μg/ml; ceftriaxone (Cro), MIC >16 μg/mL; ceftazidime (Caz), MIC >16 μg/mL.

Main Article

Page created: July 23, 2012
Page updated: July 23, 2012
Page reviewed: July 23, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external